IRIDEX Accounts Payable vs Current Deferred Revenue Analysis

IRIX Stock

USD 2.87 0.09 3.04%

IRIDEX financial indicator trend analysis is infinitely more than just investigating IRIDEX recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IRIDEX is a good investment. Please check the relationship between IRIDEX Accounts Payable and its Current Deferred Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IRIDEX. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy IRIDEX Stock please use our How to Invest in IRIDEX guide.

Accounts Payable vs Current Deferred Revenue

Accounts Payable vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IRIDEX Accounts Payable account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between IRIDEX's Accounts Payable and Current Deferred Revenue is 0.7. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of IRIDEX, assuming nothing else is changed. The correlation between historical values of IRIDEX's Accounts Payable and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of IRIDEX are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Accounts Payable i.e., IRIDEX's Accounts Payable and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.7

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents IRIDEX obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of IRIDEX are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from IRIDEX's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IRIDEX current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IRIDEX. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy IRIDEX Stock please use our How to Invest in IRIDEX guide.Selling General Administrative is likely to drop to about 8.2 M in 2024. Discontinued Operations is likely to drop to about 375.2 K in 2024

	2021	2022	2023	2024 (projected)
Gross Profit	22.8M	25.4M	21.5M	19.0M
Total Revenue	53.9M	57.0M	51.9M	40.7M

Gross Profit Total Revenue

IRIDEX fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Property Plant And Equipment Gross	Common Stock Total Equity	Intangible Assets	Common Stock	Other Assets	Property Plant Equipment
Total Assets		0.55	0.7	0.66	0.38	-0.72	-0.26	0.5	0.81	0.48	0.08	0.81	0.88	0.58	0.82	-0.15	0.64	0.47	0.96	0.53	0.08	0.51	0.31	0.55	0.1	0.09
Other Current Liab	0.55		0.8	0.06	0.68	-0.4	-0.67	0.48	0.56	0.15	0.21	0.56	0.66	0.68	0.28	-0.11	0.81	0.63	0.57	0.14	0.31	0.77	0.36	0.78	-0.27	0.59
Total Current Liabilities	0.7	0.8		0.09	0.71	-0.37	-0.77	0.72	0.53	0.32	0.46	0.53	0.79	0.93	0.53	0.02	0.93	0.8	0.68	0.37	0.38	0.85	0.63	0.89	-0.25	0.45
Total Stockholder Equity	0.66	0.06	0.09		-0.14	-0.79	0.48	-0.25	0.66	0.2	-0.54	0.65	0.43	0.0	0.56	-0.17	0.13	-0.35	0.67	0.53	-0.54	0.05	-0.35	-0.01	0.25	-0.39
Property Plant And Equipment Net	0.38	0.68	0.71	-0.14		-0.05	-0.76	0.57	0.25	0.32	0.19	0.25	0.68	0.81	0.22	-0.3	0.82	0.67	0.32	0.14	0.42	0.85	0.47	0.86	-0.22	0.52
Net Debt	-0.72	-0.4	-0.37	-0.79	-0.05		-0.14	0.06	-0.94	0.09	0.4	-0.93	-0.46	-0.21	-0.45	0.14	-0.39	0.02	-0.83	-0.35	0.42	-0.24	0.01	-0.25	0.24	0.0
Retained Earnings	-0.26	-0.67	-0.77	0.48	-0.76	-0.14		-0.78	-0.14	-0.14	-0.63	-0.16	-0.51	-0.8	-0.17	0.06	-0.75	-0.9	-0.25	-0.12	-0.67	-0.75	-0.63	-0.81	0.36	-0.56
Accounts Payable	0.5	0.48	0.72	-0.25	0.57	0.06	-0.78		0.17	0.42	0.74	0.19	0.65	0.64	0.56	-0.09	0.57	0.91	0.42	0.1	0.78	0.53	0.69	0.62	-0.09	0.31
Cash	0.81	0.56	0.53	0.66	0.25	-0.94	-0.14	0.17		-0.05	-0.25	1.0	0.59	0.37	0.5	-0.18	0.54	0.23	0.92	0.44	-0.19	0.38	0.09	0.41	-0.32	0.1
Non Current Assets Total	0.48	0.15	0.32	0.2	0.32	0.09	-0.14	0.42	-0.05		0.22	-0.05	0.56	0.4	0.45	-0.16	0.27	0.37	0.21	0.13	0.22	0.31	0.39	0.34	0.79	0.16
Non Currrent Assets Other	0.08	0.21	0.46	-0.54	0.19	0.4	-0.63	0.74	-0.25	0.22		-0.23	0.18	0.38	0.23	0.42	0.25	0.73	0.02	-0.14	0.7	0.19	0.65	0.28	-0.07	0.29
Cash And Short Term Investments	0.81	0.56	0.53	0.65	0.25	-0.93	-0.16	0.19	1.0	-0.05	-0.23		0.6	0.36	0.5	-0.18	0.53	0.25	0.92	0.44	-0.16	0.37	0.1	0.4	-0.32	0.1
Net Receivables	0.88	0.66	0.79	0.43	0.68	-0.46	-0.51	0.65	0.59	0.56	0.18	0.6		0.76	0.8	-0.35	0.8	0.6	0.79	0.45	0.29	0.77	0.35	0.78	0.11	0.22
Common Stock Shares Outstanding	0.58	0.68	0.93	0.0	0.81	-0.21	-0.8	0.64	0.37	0.4	0.38	0.36	0.76		0.43	-0.09	0.95	0.75	0.51	0.37	0.31	0.93	0.62	0.96	-0.16	0.48
Inventory	0.82	0.28	0.53	0.56	0.22	-0.45	-0.17	0.56	0.5	0.45	0.23	0.5	0.8	0.43		-0.24	0.47	0.35	0.76	0.51	0.22	0.37	0.17	0.37	0.17	-0.19
Other Current Assets	-0.15	-0.11	0.02	-0.17	-0.3	0.14	0.06	-0.09	-0.18	-0.16	0.42	-0.18	-0.35	-0.09	-0.24		-0.19	0.01	-0.11	-0.01	-0.06	-0.3	0.2	-0.27	-0.13	-0.01
Other Stockholder Equity	0.64	0.81	0.93	0.13	0.82	-0.39	-0.75	0.57	0.54	0.27	0.25	0.53	0.8	0.95	0.47	-0.19		0.68	0.62	0.38	0.25	0.96	0.5	0.97	-0.27	0.5
Total Liab	0.47	0.63	0.8	-0.35	0.67	0.02	-0.9	0.91	0.23	0.37	0.73	0.25	0.6	0.75	0.35	0.01	0.68		0.4	0.03	0.7	0.62	0.83	0.74	-0.18	0.6
Total Current Assets	0.96	0.57	0.68	0.67	0.32	-0.83	-0.25	0.42	0.92	0.21	0.02	0.92	0.79	0.51	0.76	-0.11	0.62	0.4		0.55	0.02	0.47	0.22	0.5	-0.14	0.05
Short Long Term Debt Total	0.53	0.14	0.37	0.53	0.14	-0.35	-0.12	0.1	0.44	0.13	-0.14	0.44	0.45	0.37	0.51	-0.01	0.38	0.03	0.55		-0.01	0.33	-0.23	0.24	0.05	-0.35
Property Plant And Equipment Gross	0.08	0.31	0.38	-0.54	0.42	0.42	-0.67	0.78	-0.19	0.22	0.7	-0.16	0.29	0.31	0.22	-0.06	0.25	0.7	0.02	-0.01		0.3	0.4	0.31	-0.06	0.29
Common Stock Total Equity	0.51	0.77	0.85	0.05	0.85	-0.24	-0.75	0.53	0.38	0.31	0.19	0.37	0.77	0.93	0.37	-0.3	0.96	0.62	0.47	0.33	0.3		0.41	0.97	-0.18	0.51
Intangible Assets	0.31	0.36	0.63	-0.35	0.47	0.01	-0.63	0.69	0.09	0.39	0.65	0.1	0.35	0.62	0.17	0.2	0.5	0.83	0.22	-0.23	0.4	0.41		0.57	-0.12	0.68
Common Stock	0.55	0.78	0.89	-0.01	0.86	-0.25	-0.81	0.62	0.41	0.34	0.28	0.4	0.78	0.96	0.37	-0.27	0.97	0.74	0.5	0.24	0.31	0.97	0.57		-0.2	0.59
Other Assets	0.1	-0.27	-0.25	0.25	-0.22	0.24	0.36	-0.09	-0.32	0.79	-0.07	-0.32	0.11	-0.16	0.17	-0.13	-0.27	-0.18	-0.14	0.05	-0.06	-0.18	-0.12	-0.2		-0.18
Property Plant Equipment	0.09	0.59	0.45	-0.39	0.52	0.0	-0.56	0.31	0.1	0.16	0.29	0.1	0.22	0.48	-0.19	-0.01	0.5	0.6	0.05	-0.35	0.29	0.51	0.68	0.59	-0.18

Click cells to compare fundamentals

IRIDEX Account Relationship Matchups

IRIDEX fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	34.8M	28.0M	48.7M	42.3M	34.4M	38.2M
Other Current Liab	4.3M	3.9M	6.0M	5.1M	5.1M	4.4M
Total Current Liabilities	9.8M	8.7M	12.6M	12.5M	13.0M	9.3M
Total Stockholder Equity	22.7M	17.4M	23.3M	17.2M	9.5M	9.0M
Property Plant And Equipment Net	3.5M	1.9M	3.0M	2.1M	3.0M	1.5M
Net Debt	(9.4M)	(7.4M)	(21.2M)	(12.2M)	(4.3M)	(4.5M)
Retained Earnings	(50.6M)	(56.9M)	(62.2M)	(69.7M)	(79.0M)	(75.1M)
Accounts Payable	2.6M	1.1M	3.4M	3.9M	4.5M	4.7M
Cash	12.7M	11.6M	23.9M	13.9M	7.0M	12.7M
Non Current Assets Total	4.3M	2.6M	6.4M	6.5M	7.0M	4.4M
Non Currrent Assets Other	151K	132K	271K	1.5M	1.4M	1.5M
Cash And Short Term Investments	12.7M	11.6M	23.9M	13.9M	7.0M	13.9M
Net Receivables	9.3M	7.3M	9.7M	9.8M	9.7M	8.4M
Common Stock Shares Outstanding	13.7M	13.8M	15.4M	15.9M	16.1M	10.5M
Liabilities And Stockholders Equity	34.8M	28.0M	48.7M	42.3M	34.4M	38.2M
Inventory	8.2M	5.7M	7.6M	10.6M	9.9M	9.6M
Other Current Assets	401K	730K	1.1M	1.5M	856K	1.3M
Other Stockholder Equity	73.1M	74.2M	85.3M	86.8M	88.4M	47.7M
Total Liab	12.1M	10.6M	25.4M	25.1M	24.9M	26.2M
Total Current Assets	30.6M	25.4M	42.3M	35.8M	27.5M	33.8M
Property Plant And Equipment Gross	3.5M	449K	3.0M	2.1M	16.7M	17.6M
Accumulated Other Comprehensive Income	80K	(19K)	45K	(24K)	(52K)	(54.6K)
Common Stock Total Equity	126K	145K	147K	148K	170.2K	105.1K
Intangible Assets	84K	68K	2.2M	2.0M	1.6M	843.2K
Common Stock	147K	148K	168K	169K	172K	114.4K
Other Assets	151K	1.6M	271K	1.5M	1.7M	1.6M
Property Plant Equipment	730K	1.9M	3.0M	2.1M	2.4M	1.3M
Current Deferred Revenue	1.5M	938K	2.4M	2.4M	2.4M	1.9M
Non Current Liabilities Total	2.3M	1.9M	12.7M	12.6M	11.9M	12.5M
Short Term Debt	1.4M	2.7M	927K	1.0M	995K	945.3K
Other Liab	535K	392K	11.0M	11.9M	13.7M	14.3M
Net Tangible Assets	22.1M	16.8M	20.1M	14.3M	12.9M	20.2M
Retained Earnings Total Equity	(29.0M)	(41.8M)	(50.6M)	(56.9M)	(51.2M)	(48.7M)
Capital Surpluse	59.4M	71.5M	73.1M	74.2M	85.3M	58.5M
Non Current Liabilities Other	2.3M	22K	25K	26K	23.4K	22.2K
Net Invested Capital	22.7M	19.9M	23.3M	17.2M	9.5M	17.5M
Net Working Capital	20.8M	16.7M	29.6M	23.3M	14.5M	18.6M
Capital Stock	147K	148K	168K	169K	172K	174.0K

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IRIDEX in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IRIDEX's short interest history, or implied volatility extrapolated from IRIDEX options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether IRIDEX offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRIDEX's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Iridex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Iridex Stock:

How To Invest In IRIDEX

Details

Is IRIDEX Stock a good investment?

Details

What is IRIDEX's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IRIDEX. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy IRIDEX Stock please use our How to Invest in IRIDEX guide.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for IRIDEX Stock analysis

When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.

	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like

Is IRIDEX's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRIDEX. If investors know IRIDEX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRIDEX listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.59)

Revenue Per Share

3.216

Quarterly Revenue Growth

(0.18)

Return On Assets

(0.16)

Return On Equity

(0.72)

The market value of IRIDEX is measured differently than its book value, which is the value of IRIDEX that is recorded on the company's balance sheet. Investors also form their own opinion of IRIDEX's value that differs from its market value or its book value, called intrinsic value, which is IRIDEX's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRIDEX's market value can be influenced by many factors that don't directly affect IRIDEX's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between IRIDEX's value and its price as these two are different measures arrived at by different means. Investors typically determine if IRIDEX is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRIDEX's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IRIDEX Accounts Payable vs Current Deferred Revenue Analysis

Accounts Payable vs Current Deferred Revenue

Accounts Payable vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Accounts Payable

Current Deferred Revenue

IRIDEX fundamental ratios Correlations

IRIDEX Account Relationship Matchups

High Positive Relationship

High Negative Relationship

IRIDEX fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for IRIDEX Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 0.97	Other Stockholder Equity
Common Stock	+ 0.97	Common Stock Total Equity
Total Current Assets	+ 0.96	Total Assets
Common Stock	+ 0.96	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.96	Other Stockholder Equity

Cash	- 0.94	Net Debt
Cash And Short Term Investments	- 0.93	Net Debt
Total Liab	- 0.9	Retained Earnings
Total Current Assets	- 0.83	Net Debt
Common Stock	- 0.81	Retained Earnings
Common Stock Shares Outstanding	- 0.8	Retained Earnings